Glucocorticoid administration for Graves' hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association

Journal of Endocrinological Investigation

Volumn 33, Issue 6, 2010, Pages 409-413

  Lazarus, J H ^a   Bartalena, L ^b   Marcocci, C ^c   Kahaly, G J ^d   Krassas, G ^e   Wiersinga, W M ^f  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e PANAGIA GENERAL HOSPITAL   (Greece)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Glucocorticoids; Graves' disease; Graves' orbitopathy; Hyperthyroidism; Questionnaire

Indexed keywords

LEVOTHYROXINE; PREDNISOLONE; PREDNISONE; RADIOACTIVE IODINE; GLUCOCORTICOID;

ARTICLE; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CORTICOSTEROID THERAPY; DISEASE COURSE; ENDOCRINE OPHTHALMOPATHY; EUROPE; EYE DISEASE; GRAVES DISEASE; HEALTH SURVEY; HUMAN; PHYSICIAN; PROPHYLAXIS; QUESTIONNAIRE; RISK FACTOR; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; GRAVES OPHTHALMOPATHY; HYPERTHYROIDISM;

GLUCOCORTICOIDS; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; PREDNISOLONE; PREDNISONE;

EID: 77955368665     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/bf03346613     Document Type: Article

References (17)

1. Lazarus JH, Marinò M. Orbit-thyroid relationship. In: Wiersinga WM, Kahaly GJ eds. Graves' orbitopathy: a multidisciplinary approach. Basel: Karger. 2007, 27-33.
2. Kendall-Taylor P. Natural history. In: Wiersinga WM, Kahaly GJ eds. Graves' orbitopathy: a multidisciplinary approach. Basel: Karger. 2007, 78-87.
3. Bartalena L, Tanda ML. Graves' ophthalmopathy. N Engl J Med 2009, 360: 994-1001.
4. Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 2000, 21: 168-99.
5. Acharya SH, Avenell A, Philip S, Burr J, Bevan JS, Abraham P. Radioiodine therapy (RAI) for Graves'disease and the effect on ophthalmopathy: a systematic review. Clin Endocrinol (Oxf) 2008, 69: 943-50.
6. Tallstedt L, Lundell G, Torring O, et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. N Engl J Med 1992, 326: 1733-8.
7. Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998, 338: 73-8.
8. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989, 321: 1349-52.
9. Vaidya B, Williams GR, Abraham P, Pearce SHS. Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists. Clin Endocrinol (Oxf) 2008, 68: 814-20.
10. Tanda ML, Lai A, Bartalena L. Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions. Clin Endocrinol (Oxf) 2008, 69: 845-7.
11. Lazarus JH. Guidelines for the use of radioiodine in the management of hyperthyroidism: a summary. Report on behalf of the Radioiodine Audit Subcommittee & the Research Unit of the Royal College of Physicians. J R Coll Physicians Lond 1995, 29: 464-9.
12. Solomon B, Glinoer D, Lagasse R, Wartofsky L. Current trends in the management of Graves' disease. J Clin Endocrinol Metab 1990, 70: 1518-24.
13. Marcocci C, Pinchera, A. Thyroid treatment. In: Wiersinga WM, Kahaly GJ eds. Graves' orbitopathy: a multidisciplinary approach. Basel: Karger. 2007, 100-10.
14. Jensen BE, Bonnema SJ, Hegedüs L. Glucocorticoids do not influence the effect of radioiodine therapy in Graves' disease. Eur J Endocrinol 2005, 153: 15-21.
15. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Torring O. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 2008, 158: 69-75.
16. Bartalena L, Baldeschi L, Dickinson J, et al. Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 2008, 158: 273-85.
17. Gamstedt A, Karlsson A. Pretreatment with betamethasone of patients with Graves' disease given radioiodine therapy: thyroid autoantibody responses and outcome of therapy. J Clin Endocrinol Metab 1991, 73: 125-31.